Serrated polyps as precursor lesions of colorectal cancer: current status and future directions. Mini-review.


  • І. О. Kuzo Zaporizhzhia State Medical University, Ukraine,



Colonic Polyps, Colorectal Cancer, Histology, Mutation, Adenocarcinoma


Early diagnosis of colorectal cancer (CRC) is a very urgent problem, since this disease has second place among women and the third one among men in the structure of cancer pathology. According to recent data, CRC should be considered as a heterogeneous multifactorial family of diseases with different variants.

Serrated polyps of the colon are obligate precancerous condition, which can transform into cancer due to genetic aberrations. Serrated polyps are a heterogeneous group of formations with different ways of appearance and potential malignancy. They are divided into major subtypes: hyperplastic polyps, sessile serrated adenoma/polyp and traditional serrated adenoma.

The purpose of the study was the analysis of current data about mechanisms of formation and malignization of serrated colonic polyps.

The relationship between the localization of serrated polyps and their morphology was identified. Polyps located in the proximal colon are characterized by a more expressed degree of serration in the basal segment of crypts compared with polyps located in the distal part of the colon. The difference between the proximal and distal localization was confirmed by molecular genetic testing: the majority of proximal serrated polyps develops after BRAF mutations, and the majority of polyps with distal localization develops after a KRAS mutation.

It is known that a key role in the excessive proliferation and inhibition of apoptosis in the process of malignant transformation of serrated polyps is provided by the combination of different types of genome damage, both genetic and epigenetic. Molecular changes are already present in the early stages of cell dysplasia in serrated colon polyps, and their nature determines the malignant potential.

Conclusions. A thorough study of the molecular mechanisms of progression along the serrated pathway and transformation of serrated polyps in the CRC opens up prospects for the development of guidelines for patient management in order to prevent the development of serrated pathway cancers.


Jemal, A., Bray, F., Center, M., Ferlay, J., Ward, E., & Forman, D. (2011). Global cancer statistics. CA: A Cancer Journal For Clinicians, 61(2), 69–90. doi: 10.3322/caac.20107.

Forsberg, A., Kjellström, L., Agréus, L., Nixon Andreasson, A., Nyhlin, H., Talley, N., & Björck, E. (2012). Prevalence of colonic neoplasia and advanced lesions in the normal population: a prospective population-based colonoscopy study. Scandinavian Journal Of Gastroenterology, 47(2), 184–190. doi: 10.3109/00365521.2011.647062.

Huth, L., Jäkel, J., & Dahl, E. (2014). Molecular Diagnostic Applications in Colorectal Cancer. Microarrays, 3(3), 168–179. doi: 10.3390/microarrays3030168.

Singh, R., Zorrón Cheng Tao Pu, L., Koay, D., & Burt, A. (2016). Sessile serrated adenoma/polyps: Where are we at in 2016? World Journal Of Gastroenterology, 22(34), 7754. doi: 10.3748/wjg.v22.i34.7754.

Schell, M., Yang, M., Teer, J., Lo, F., Madan, A., Coppola, D. et al. (2016). A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC. Nature Communications, 7, 11743. doi: 10.1038/ncomms11743.

Anderson, J., Rangasamy, P., Rustagi, T., Myers, M., Sanders, M., Vaziri, H. et al. (2011). Risk Factors for Sessile Serrated Adenomas. Journal Of Clinical Gastroenterology, 45(8), 694–699. doi: 10.1097/MCG.0b013e318207f3cf.

Buchanan, D., Sweet, K., Drini, M., Jenkins, M., Win, A., Gattas, M. et al. (2010). Phenotypic diversity in patients with multiple serrated polyps: a genetics clinic study. International Journal Of Colorectal Disease, 25(6), 703–712. doi: 10.1007/s00384-010-0907-8.

Wish, T., Hyde, A., Parfrey, P., Green, J., Younghusband, H., Simms, M. et al. (2010). Increased Cancer Predisposition in Family Members of Colorectal Cancer Patients Harboring the p.V600E BRAF Mutation: a Population-Based Study. Cancer Epidemiology Biomarkers & Prevention, 19(7), 1831–1839. doi: 10.1158/1055-9965.EPI-10-0055.

Samadder, N., Vierkant, R., Tillmans, L., Wang, A., Weisenberger, D., Laird, P. et al. (2013). Associations Between Colorectal Cancer Molecular Markers and Pathways With Clinicopathologic Features in Older Women. Gastroenterology, 145(2), 348–356.e2. doi: 10.1053/j.gastro.2013.05.001.

(2015). UEG Week 2015 Poster Presentations. United European Gastroenterology Journal, 3(5 Suppl), 146–687. doi: 10.1177/2050640615601623.

Anderson, J., Swede, H., Rustagi, T., Protiva, P., Pleau, D., Brenner, B. et al. (2012). Aberrant crypt foci as predictors of colorectal neoplasia on repeat colonoscopy. Cancer Causes & Control, 23(2), 355–361. doi: 10.1007/s10552-011-9884-7.

Murcia, O., Juárez, M., Hernández-Illán, E., Egoavil, C., Giner-Calabuig, M., Rodríguez-Soler, M., Jover, R. (2016). Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapy. World Journal Of Gastroenterology, 22(13), 3516–3530. doi: 10.3748/wjg.v22.i13.3516.

Nagtegaal, I. & Hugen, N. (2015). The Increasing Relevance of Tumour Histology in Determining Oncological Outcomes in Colorectal Cancer. Curr Colorectal Cancer Rep, 11(5), 259–266. doi: 10.1007/s11888-015-0280-7.

Rex, D., Ahnen, D., Baron, J., Batts, K., Burke, C., Burt, R. et al. (2012). Serrated Lesions of the Colorectum: Review and Recommendations From an Expert Panel. The American Journal Of Gastroenterology, 107(9), 1315–1329. doi: 10.1038/ajg.2012.161.

Shussman, N. & Wexner, S. (2014). Colorectal polyps and polyposis syndromes. Gastroenterology Report, 2(1), 1–15. doi: 10.1093/gastro/got041.

Longacre, T. & Fenoglio-Preiser, C. (1990). Mixed Hyperplastic Adenomatous Polyps/Serrated Adenomas. The American Journal Of Surgical Pathology, 14(6), 524–537. doi: 10.1097/00000478-199006000-00003.

Torlakovic, E. & Snover, D. (1996). Serrated adenomatous polyposis in humans. Gastroenterology, 110(3), 748–755. doi: 10.1053/gast.1996.v110.pm8608884.

Snover, D., Jass, J., Fenoglio-Preiser, C., & Batts, K. (2005). Serrated Polyps of the Large Intestine: A Morphologic and Molecular Review of an Evolving Concept. American Journal Of Clinical Pathology, 124(3), 380–391. doi: 10.1309/V2EP-TPLJ-RB3F-GHJL.

Cekodhima, G., Cekodhima, A., Beqiri, A., Alimehmeti, M., & Sulo, G. (2016). Demographic And Histopathological Characteristics Of Colorectal Polyps: A Descriptive Study Based On Samples Obtained From Symptomatic Patients. Slovenian Journal Of Public Health, 55(2). doi: 10.1515/sjph-2016-0016.

Carragher, L., Snell, K., Giblett, S., Aldridge, V., Patel, B., Cook, S. et al. (2010). V600E Braf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16 INK4a. EMBO Molecular Medicine, 2(11), 458–471. doi: 10.1002/emmm.201000099.

Snover, D. (2011). Update on the serrated pathway to colorectal carcinoma. Human Pathology, 42(1), 1–10. doi: 10.1016/j.humpath.2010.06.002.

Kahi, C., Li, X., Eckert, G., & Rex, D. (2012). High colonoscopic prevalence of proximal colon serrated polyps in average-risk men and women. Gastrointestinal Endoscopy, 75(3), 515–520. doi: 10.1016/j.gie.2011.08.021.

Sinicrope, F., Shi, Q., Smyrk, T., Thibodeau, S., Dienstmann, R., Guinney, J. et al. (2015). Molecular Markers Identify Subtypes of Stage III Colon Cancer Associated With Patient Outcomes. Gastroenterology, 148(1), 88–99. doi: 10.1053/j.gastro.2014.09.041.

Bettington, M., Walker, N., Clouston, A., Brown, I., Leggett, B., & Whitehall, V. (2013). The serrated pathway to colorectal carcinoma: current concepts and challenges. Histopathology, 62(3), 367–386. doi: 10.1111/his.12055.

Rex, D., Ahnen, D., Baron, J., Batts, K., Burke, C., Burt,R. et al. (2012). Serrated Lesions of the Colorectum: Review and Recommendations From an Expert Panel. The American Journal Of Gastroenterology, 107(9), 1315–1329. doi: 10.1038/ajg.2012.161.

Fujimori, Y., Fujimori, T., Imura, J., Sugai, T., Yao, T., Wada, R. et al. (2012). An assessment of the diagnostic criteria for sessile serrated adenoma/polyps: SSA/Ps using image processing software analysis for Ki67 immunohistochemistry. Diagnostic Pathology, 7(1). doi: 10.1186/1746-1596-7-59.

Crockett, S., Snover, D., Ahnen, D., & Baron, J. (2015). Sessile Serrated Adenomas: An Evidence-Based Guide to Management. Clinical Gastroenterology And Hepatology, 13(1), 11–26.e1. doi: 10.1016/j.cgh.2013.10.035.

Lin, Y., Chiu, H., Lee, Y., Shun, C., Wang, H., & Wu, M. (2014). Hyperplastic polyps identified during screening endoscopy: Reevaluated by histological examinations and genetic alterations. Journal Of The Formosan Medical Association, 113(7), 417–421. doi: 10.1016/j.jfma.2012.07.030.

Yuyucu Karabulut, Y., Savas, B., Kursun, N., & Ensar, A. (2014). Serrated lesions of the appendix: Do they differ from their colorectal counterparts?. The Turkish Journal Of Gastroenterology, 25(1), 29–34. doi: 10.5152/tjg.2014.4056.

Rau, T., Agaimy, A., Gehoff, A., Geppert, C., Jung, K., Knobloch, K. et al. (2014). Defined morphological criteria allow reliable diagnosis of colorectal serrated polyps and predict polyp genetics. Virchows Archiv, 464(6), 663–672. doi: 10.1007/s00428-014-1569-7.

Obuch, J., Pigott, C., & Ahnen, D. (2015). Sessile Serrated Polyps: Detection, Eradication, and Prevention of the Evil Twin. Current Treatment Options In Gastroenterology, 13(1), 156–170. doi: 10.1007/s11938-015-0046-y.

Rosty, C., Hewett, D., Brown, I., Leggett, B., & Whitehall, V. (2012). Serrated polyps of the large intestine: current understanding of diagnosis, pathogenesis, and clinical management. Journal Of Gastroenterology, 48(3), 287–302. doi: 10.1007/s00535-012-0720-y.

Ko, H., Harpaz, N., McBride, R., Cui, M., Ye, F., Zhang, D. et al. (2015). Serrated colorectal polyps in inflammatory bowel disease. Mod Pathol, 28(12), 1584–1593. doi: 10.1038/modpathol.2015.111.

Gonzalo, D., Lai, K., Shadrach, B., Goldblum, J., Bennett, A., Downs-Kelly, E. et al. (2013). Gene expression profiling of serrated polyps identifies annexin A10 as a marker of a sessile serrated adenoma/polyp. The Journal Of Pathology, 230(4), 420–429. doi: 10.1002/path.4200.

Minarikova, P., Benesova, L., Halkova, T., Belsanova, B., Suchanek, S., Cyrany, J. et al. (2016). Longitudinal molecular characterization of endoscopic specimens from colorectal lesions. World Journal Of Gastroenterology, 22(20), 4936. doi: 10.3748/wjg.v22.i20.4936.

Saiki, H., Nishida, T., Yamamoto, M., Hayashi, S., Shimakoshi, H., Shimoda, A., et al. (2016). Frequency of coexistent carcinoma in sessile serrated adenoma/polyps and traditional serrated adenomas removed by endoscopic resection. Endosc Int Open, 04(04), E451-E458. doi: 10.1055/s-0042-103239.

Zhao, X., Zhan, Q., Xiang, L., Wang, Y., Wang, X., Li, A., & Liu, S. (2014). Clinicopathological Characteristics of Laterally Spreading Colorectal Tumor. Plos ONE, 9(4), e94552. doi: 10.1371/journal.pone.0094552.

Fu, X., Qiu, Y., & Zhang, Y. (2014). Screening, management and surveillance for the sessile serrated adenomas/polyps. Int J Clin Exp Pathol, 7(4), 1275–1285.

Miwata, T., Hiyama, T., Oka, S., Tanaka, S., Shimamoto, F., Arihiro, K., & Chayama, K. (2013). Clinicopathologic features of hyperplastic/serrated polyposis syndrome in Japan. J Gastroenterol Hepatol, 28(11), 1693–1698. doi: 10.1111/jgh.12307.

Kalady, M., Jarrar, A., Leach, B., LaGuardia, L., OʼMalley, M., Eng, C., & Church, J. (2011). Defining Phenotypes and Cancer Risk in Hyperplastic Polyposis Syndrome. Diseases Of The Colon & Rectum, 54(2), 164–170. doi: 10.1007/DCR.0b013e3181fd4c15.

Boparai, K., Reitsma, J., Lemmens, V., van Os, T., Mathus-Vliegen, E., Koornstra, J. et al. (2010). Increased colorectal cancer risk in first-degree relatives of patients with hyperplastic polyposis syndrome. Gut, 59(9), 1222–1225. doi: 10.1136/gut.2009.200741.

Carballal, S., Rodríguez-Alcalde, D., Moreira, L., Hernández, L., Rodríguez, L., Rodríguez-Moranta, F. et al. (2015). Colorectal cancer risk factors in patients with serrated polyposis syndrome: a large multicentre study. Gut, gutjnl-2015-309647. doi: 10.1136/gutjnl-2015-309647.

Coghlin, C. & Murray, G. (2015). Biomarkers of colorectal cancer: Recent advances and future challenges. PROTEOMICS - Clinical Applications, 9(1-2), 64–71. doi: 10.1002/prca.201400082.

Geiersbach, K. & Samowitz, W. (2011). Microsatellite Instability and Colorectal Cancer. Archives Of Pathology & Laboratory Medicine, 135(10), 1269–1277. doi: 10.5858/arpa.2011-0035-RA.

Leggett, B. & Whitehall, V. (2010). Role of the Serrated Pathway in Colorectal Cancer Pathogenesis. Gastroenterology, 138(6), 2088–2100. doi: 10.1053/j.gastro.2009.

Spring, K., Zhao, Z., Karamatic, R., Walsh, M., Whitehall, V., Pike, T. et al. (2006). High Prevalence of Sessile Serrated Adenomas With BRAF Mutations: A Prospective Study of Patients Undergoing Colonoscopy. Gastroenterology, 131(5), 1400–1407. doi: 10.1053/j.gastro.2006.08.038.

Rosenberg, D., Yang, S., Pleau, D., Greenspan, E., Stevens, R., Rajan, T. et al. (2007). Mutations in BRAF and KRAS Differentially Distinguish Serrated versus Non-Serrated Hyperplastic Aberrant Crypt Foci in Humans. Cancer Research, 67(8), 3551–3554. doi: 10.1158/0008-5472.CAN-07-0343.

Mohammadi, M., Kristensen, M., Nielsen, H., Bonde, J., & Holck, S. (2012). Qualities of sessile serrated adenoma/polyp/lesion and its borderline variant in the context of synchronous colorectal carcinoma. Journal Of Clinical Pathology, 65(10), 924–927. doi:10.1136/jclinpath-2012-200803.

Carr, N., Tan, K., Mahajan, H., Hawkins, N., Ward, R., & Nguyen, Q. (2009). Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. Pathology, 41, 66. doi: 10.1097/01268031-200941001-00151.


How to Cite

Kuzo ІО. Serrated polyps as precursor lesions of colorectal cancer: current status and future directions. Mini-review. Pathologia [Internet]. 2016Oct.27 [cited 2024Apr.21];13(2). Available from: